1. Academic Validation
  2. Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways

Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways

  • Cytokine. 2024 Nov:183:156737. doi: 10.1016/j.cyto.2024.156737.
Fei Xie 1 Yoshinori Kitagawa 2 Hiroki Ogata 2 Shingo Yasuhara 2 Zerong You 2 J A Jeevendra Martyn 3
Affiliations

Affiliations

  • 1 Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China; Harvard Medical School, Boston, MA, USA; Shriners Hospital for Children - Boston, Boston, MA, USA.
  • 2 Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Hospital for Children - Boston, Boston, MA, USA.
  • 3 Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Hospital for Children - Boston, Boston, MA, USA. Electronic address: JMARTYN@mgh.harvard.edu.
Abstract

Background: Opioid activation of the microglia or macrophage Toll-like Receptor 4 (TLR4) and associated inflammatory cytokine release are implicated in opioid-induced hyperalgesia and tolerance. The Cyclic GMP-AMP Synthase/stimulator of interferon genes (cGAS-STING) signaling pathway, activated by double-stranded DNA including mitochondrial DNA (mtDNA), has emerged as another key mediator of inflammatory responses. This study tested the hypothesis that morphine induces immune inflammatory responses in microglia and macrophages involving TLR4 and cGAS-STING pathway.

Methods: BV2 microglia and Raw 264.7 (Raw) macrophage cells were exposed to morphine with and without a STING Inhibitor (C176) for 6 h or TLR 4 inhibitor (TAK242) for 24 h. Western blotting and RT-qPCR analyses assessed TLR4, cGAS, STING, nuclear factor-kappa B (NF-κB), and pro-inflammatory cytokine expression. Morphine-induced mitochondria dysfunction was quantified by Reactive Oxygen Species (ROS) release using MitoSOX, mtDNA release by immunofluorescence, and RT-qPCR. Polarization of BV2 and Raw cells was assessed by inducible nitric oxide (iNOS) and CD86 expression. The role of mtDNA on morphine-related inflammation was investigated by mtDNA depletion of the cells with ethidium bromide (EtBr) or Cell Transfection of mtDNA extracted from morphine-treated cells.

Results: Morphine significantly increased the expression of TLR4, cGAS, STING, p65 NF-κB, and cytokines (IL-6 and TNF-α) in BV2 and Raw cells. Morphine-induced mitochondrial dysfunction by increased ROS and mtDNA release; the increased iNOS and CD86 evidenced inflammatory M1-like phenotype polarization. TLR4 and STING inhibitors reduced morphine-induced cytokine release in both cell types. The transfection of mtDNA activated inflammatory signaling proteins, cytokine release, and polarization. Conversely, mtDNA depletion led to the reversal of these effects.

Conclusion: Morphine activates the cGAS-STING pathway in macrophage cell types. Inhibition of the STING pathway can be an additional method to overcome immune cell inflammation-related morphine tolerance and opioid-induced hyperalgesia.

Keywords

Inflammation; Morphine; NF-κB; Polarization; TLR4; cGAS-STING.

Figures
Products